Open access · CC-BY
via OpenAlex
GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective
Journal of Diabetes Research · 2015 · ▲ 472 citations
Abstract
Growth differentiation factor-15 (GDF-15) is a stress responsive cytokine. It is highly expressed in cardiomyocytes, adipocytes, macrophages, endothelial cells, and vascular smooth muscle cells in normal and pathological condition. GDF-15 increases during tissue injury and inflammatory states and is associated with cardiometabolic risk. Increased GDF-15 levels are associated with cardiovascular diseases such as hypertrophy, heart failure, atherosclerosis, endothelial dysfunction, obesity, insulin resistance, diabetes, and chronic kidney diseases in diabetes. Increased GDF-15 level is linked with the progression and prognosis of the disease condition. Age, smoking, and environmental factors are other risk factors that may increase GDF-15 level. Most of the scientific studies reported that GDF-15 plays a protective role in different tissues. However, few reports show that the deficiency of GDF-15 is beneficial against vascular injury and inflammation. GDF-15 protects heart, adipose tissue, and endothelial cells by inhibiting JNK (c-Jun N-terminal kinase), Bad (Bcl-2-associated death promoter), and EGFR (epidermal growth factor receptor) and activating Smad, eNOS, PI3K, and AKT signaling pathways. The present review describes the different animal and clinical studies and patent updates of GDF-15 in diabetes and cardiovascular diseases. It is a challenge for the scientific community to use GDF-15 information for patient monitoring, clinical decision-making, and replacement of current treatment strategies for diabetic and cardiovascular diseases.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1155/2015/490842
- Canonical
- link ↗
- Fetched
- 2026-07-28 MST
Cite this
APA
Adela, R., & Banerjee, S. (2015). GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective. <em>Journal of Diabetes Research</em>. https://doi.org/10.1155/2015/490842
Vancouver
Adela R, Banerjee S. GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective. Journal of Diabetes Research. 2015. doi:10.1155/2015/490842.
BibTeX
@article{ramu2015GDFasa,
title = {GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective},
author = {Ramu Adela and S. Banerjee},
journal = {Journal of Diabetes Research},
year = {2015},
doi = {10.1155/2015/490842},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
American Journal of Hypertension 2002
Open access · OA
Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications
European Journal of Cardiovascular Prevention & Rehabilitation 2006
Open access · OA
Endothelial progenitor cells: a new target for the prevention of cardiovascular diseases
PubMed 2007
Preprint · OA
Telomere shortening & metabolic/vascular diseases.
Frontiers in bioscience 2009
Open access · OA
The role of endothelial progenitor and cardiac stem cells in the cardiovascular adaptations to age and exercise
Circulation Research 2008
Open access · OA
Role of Mitochondrial Dysfunction in Insulin Resistance
University of Lausanne 2010
Open access · US-GOV